The response of Dual-leucine zipper kinase (DLK) to nocodazole: Evidence for a homeostatic cytoskeletal repair mechanism

PLoS One. 2024 Apr 4;19(4):e0300539. doi: 10.1371/journal.pone.0300539. eCollection 2024.

Abstract

Genetic and pharmacological perturbation of the cytoskeleton enhances the regenerative potential of neurons. This response requires Dual-leucine Zipper Kinase (DLK), a neuronal stress sensor that is a central regulator of axon regeneration and degeneration. The damage and repair aspects of this response are reminiscent of other cellular homeostatic systems, suggesting that a cytoskeletal homeostatic response exists. In this study, we propose a framework for understanding DLK mediated neuronal cytoskeletal homeostasis. We demonstrate that low dose nocodazole treatment activates DLK signaling. Activation of DLK signaling results in a DLK-dependent transcriptional signature, which we identify through RNA-seq. This signature includes genes likely to attenuate DLK signaling while simultaneously inducing actin regulating genes. We identify alterations to the cytoskeleton including actin-based morphological changes to the axon. These results are consistent with the model that cytoskeletal disruption in the neuron induces a DLK-dependent homeostatic mechanism, which we term the Cytoskeletal Stress Response (CSR) pathway.

MeSH terms

  • Actins* / metabolism
  • Axons* / metabolism
  • Cytoskeleton / metabolism
  • Homeostasis
  • Leucine Zippers
  • MAP Kinase Kinase Kinases / genetics
  • Nerve Regeneration / physiology
  • Nocodazole / pharmacology

Substances

  • Nocodazole
  • Actins
  • MAP Kinase Kinase Kinases